FDA Reannounces Public Patient Education Workshop on Prescription Drug Product Labeling

Summary

The FDA is rescheduling a public workshop to discuss methods and criteria for developing and evaluating prescription drug information for patients, following a previous postponement due to inclement weather, and is now set to take place on February 14 and 15, 1996.